Next Up

Oligonucleotide Chemistry & Therapeutics Symposium

14 September 2022 |

Online: BST (UTC+1)

14 September 2022

Online: BST (UTC+1)

An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics

08 Sep 2022
Thu, 08 September 2022

Infectious Disease: Target Profiling and Associated Key Assays to Support Vaccine Development from Early Development to Late Clinical Phase

Presented by Nexelis

22 Sep 2022
Thu, 22 September 2022

Upcoming Biologics Nexelis Webinar

Presented by Nexelis

10 Nov 2022
Thu, 10 November 2022

Upcoming Biologics Nexelis Webinar

Presented by Nexelis

Highlights

AstraZeneca Suffers Significant Sales Decline for COVID Med Evusheld
Industry Spotlight
A 24 million loss has been reported for the preventative COVID-19 treatment.
Edited by Tia Byer |
05 August 2022
Proteins & Antibodies
Industry Spotlight
Edited by Tia Byer |
03 Aug 2022
Proteins & Antibodies
Discussion Group Report
Edited by Tia Byer |
31 Jul 2022
Bispecifics

In-Depth

Discussion Group Report
Laura von Schantz, Vice President of Discovery at Alligator Bioscience, leads a discussion on the current and future opportunities of bispecific antibodies for solid tumour treatment.
31 July 2022
Commentary
Compared to non-solid tumours, solid tumours are more difficult to treat with conventional therapeutic methods. Antibody drug conjugates – biopharmaceutical drugs designed as a targeted therapy for treating cancer – represent a viable treatment alternative.
26 July 2022
Commentary
Nexelis Principal Scientist, Annett Kleinschmidt, explains the company’s efforts in measuring bactericidal antibody response.
19 July 2022
Insight Article
Key opinion leaders from AbbVie, Ambrx Inc, and Antikor Biopharma talk about the cutting-edge technology’s promise for better therapeutic index.
04 July 2022

Industry Spotlight

Industry Spotlight
A 24 million loss has been reported for the preventative COVID-19 treatment.
05 August 2022
Industry Spotlight
Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
03 August 2022
Industry Spotlight
The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
29 July 2022
Industry Spotlight
Oxford Global’s next round of Biologics Discussion Groups announced.
27 July 2022

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login